VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3307
ETF rank
โ‚น2.34 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น2,691
Share price
-1.68%
Change (1 day)
37.82%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of October 2026: 0.35%